Ketoisdin (Ketoconazole)

Ketoconazole inhibits the fungal enzyme lanosterol 14α‑demethylase, which is essential for synthesising ergosterol, a key component of fungal cell membranes. By blocking ergosterol production, the drug compromises membrane integrity, leading to fungal cell death and clearance of the infection.

The specific dosage and frequency of Ketoisdin are determined by the prescribing healthcare professional based on the infection type, severity, patient age, and treatment area. Patients should follow the prescriber’s instructions and the product label for optimal results.

Safety data for topical ketoconazole in pregnancy and lactation are limited. Healthcare providers generally weigh the benefits against potential risks before prescribing. Women who are pregnant, planning to become pregnant, or breastfeeding should discuss alternative treatments with their clinician.

To request Ketoisdin, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements), and necessary import documentation.

Ketoisdin (ketoconazole) belongs to the imidazole class, offering broad‑spectrum activity against dermatophytes and yeasts. Compared with allylamine agents such as terbinafine, ketoconazole may be less irritating but can have a higher risk of systemic absorption and liver effects when used over large areas. Choice of therapy depends on infection type, patient factors, and clinician preference.

Ketoisdin should be stored below 25 °C (77 °F) in its original packaging. Keep the product away from moisture, direct sunlight, and excessive heat to maintain stability and potency throughout its shelf life.

Ketoisdin is applied topically to the affected skin area, usually once or twice daily as directed by the prescriber. The skin should be clean and dry before application, and the medication should be spread in a thin layer, gently massaged until fully absorbed.

While rare, serious adverse reactions can include severe allergic skin reactions such as contact dermatitis, systemic hepatotoxicity from significant absorption, and, in extremely uncommon cases, Stevens‑Johnson syndrome. Patients should seek immediate medical attention if they notice extensive rash, blistering, jaundice, or other systemic symptoms.

Ketoisdin should be avoided in individuals with known hypersensitivity to ketoconazole or any component of the formulation. It is also contraindicated on broken or inflamed skin, and caution is advised for patients with pre‑existing liver disease or those taking other hepatotoxic medications.